Host: Matthew J. Sorrentino, MD, FACC, FASH

Guest: Paul Chan, MD

Are high-dose statins cost effective for patients after acute coronary syndromes or for patients with chronic coronary disease? Dr. Paul Chan discusses his recent paper in Circulation and his cost-effectiveness analysis.